News from neodyne biosciences, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Sep 10, 2014, 09:00 ET

Neodyne Biosciences Data Now Published in Plastic & Reconstructive Surgery Shows Long-Term Effectiveness of the EMBRACE® Device in Reducing Scar Formation

Neodyne Biosciences announced today that favorable 1 year follow-up results from the pivotal multi-center, randomized, controlled trial of the...

Jul 22, 2014, 09:00 ET

Neodyne Biosciences, Inc., Manufacturer of embrace® Advanced Scar Therapy, Receives Notice of Allowance for Korean Patent

 Neodyne Biosciences, a medical device company focused on the development and commercialization of innovative tissue repair devices to promote...

May 15, 2014, 08:30 ET

New 1-year Follow-up Data Demonstrate Highly Significant Long-term Improvement in Scarring using Neodyne Biosciences embrace® Advanced Scar Therapy

In the largest randomized, controlled trial to date of the embrace® Advanced Scar Therapy device, Neodyne Biosciences reported a highly...

Apr 23, 2014, 15:00 ET

Neodyne Biosciences announces schedule of presentations on embrace® Advanced Scar Therapy at The Aesthetic Meeting 2014

Neodyne Biosciences, a medical device company focused on the development and commercialization of innovative tissue repair devices to promote...

Mar 20, 2014, 08:30 ET

Neodyne Biosciences Issued 8th US Patent for embrace® Advanced Scar Therapy

Neodyne Biosciences, a medical device company focused on the development and commercialization of innovative tissue repair devices to promote...

Feb 25, 2014, 08:30 ET

Neodyne Biosciences Partners with The Strouse Corporation to Scale Production of embrace® Advanced Scar Therapy

 Neodyne Biosciences, a medical device company focused on the development and commercialization of innovative tissue repair devices to promote...

Jan 30, 2014, 09:30 ET

Neodyne Biosciences Reports Published Favorable Results of a Prospective, Randomized Controlled Study Showing Significantly Reduced Scarring Using embrace® Advanced Scar Therapy

 Neodyne Biosciences, a medical device company focused on the development and commercialization of innovative tissue repair devices to...

Dec 03, 2013, 08:30 ET

Neodyne Biosciences Announces Issuance of U.S. Patent for Devices and Methods for Dressing Applicators

Neodyne Biosciences, a medical device company focused on the development and commercialization of innovative tissue repair devices to promote...

Oct 28, 2013, 09:30 ET

Neodyne Biosciences Announces 94% Market Adoption and 91% Re-order Rate of embrace® Advanced Scar Therapy among Plastic Surgeons in Las Vegas Test Market

 Neodyne Biosciences, Inc., today announced 94 percent market adoption and a 91 percent re-order rate of embrace® Advanced Scar Therapy...

Oct 15, 2013, 12:07 ET

Neodyne Biosciences, Inc. announces that early clinical experience with embrace® Advanced Scar Therapy will be presented at the 2013 Annual Meeting of the American Society of Plastic Surgery in San Diego, CA

 Neodyne Biosciences, Inc., announced today that Geoffrey Gurtner, MD, FACS, of Stanford University and Ali Mosharrafa, MD, of Phoenix, AZ will...

Feb 05, 2013, 09:05 ET

Neodyne Biosciences Announces its First Commercial Sales for Patented embrace™ Advanced Scar Therapy to Plastic Surgeons in the Las Vegas Market

 Neodyne Biosciences, Inc., today announced positive reception and product sales for its first commercially available product,  patented...

Aug 07, 2012, 12:09 ET